{"id":"NCT03851705","sponsor":"Novartis Pharmaceuticals","briefTitle":"A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH)","officialTitle":"A Two-Part (Double-Blind Placebo Controlled/Open-Label) Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Subjects With Homozygous Familial Hypercholesterolemia (Hofh) (ORION-5)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-02-06","primaryCompletion":"2020-03-02","completion":"2021-09-09","firstPosted":"2019-02-22","resultsPosted":"2022-11-10","lastUpdate":"2023-01-30"},"enrollment":56,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Homozygous Familial Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"Inclisiran Sodium for injection","otherNames":["ALN-PCSSC; KJX839","ALN-PCSSC"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Placebos","otherNames":[]}],"arms":[{"label":"Part 1 - Inclisiran","type":"EXPERIMENTAL"},{"label":"Part 1 - Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Part 2 - Inclisiran","type":"EXPERIMENTAL"}],"summary":"This study was a Phase III,A two-part (double-blind placebo-controlled/open-label) multicenter study to evaluate safety, tolerability, and efficacy of inclisiran in subjects with homozygous familial hypercholesterolemia (HoFH).","primaryOutcome":{"measure":"Percent Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline to Day 150","timeFrame":"Baseline, Day 150","effectByArm":[{"arm":"Part 1 - Placebo","deltaMin":2.39,"sd":null},{"arm":"Part 1 - Inclisiran","deltaMin":0.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.9047"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":13,"countries":["Hong Kong","Israel","Russia","Serbia","South Africa","Taiwan","Turkey (TÃ¼rkiye)","Ukraine"]},"refs":{"pmids":["37850379","33990512"],"seeAlso":["https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=1197"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":37},"commonTop":["Respiratory tract infection viral","Anaemia","Angina pectoris","Diarrhoea","Pyrexia"]}}